Introduction
Autoimmune thyroid diseases are the most common form of autoimmune disorders occurring in patients with type 1 diabetes [1] and the most common autoimmune endocrinopathy occurring in their families [2, 3] . The frequency of thyroid autoimmune disease and the prevalence of thyroid autoantibodies (TAA) in patients with type 1 diabetes varies widely between 3 and 50% [4, 5] and is often related to age, gender or ethnic origin, whereas thyroid dysfunction has been reported in approximately 8% of patients [6] . Hashimoto's thyroiditis (chronic autoimmune thyroiditis) and Graves' disease (thyromegaly and hyperthyroidism) are the major autoimmune thyroid diseases that occur with increased frequency in patients with type 1 diabetes.
TAA are specific markers for autoimmune thyroid diseases with expression typically higher in Hashimoto's thyroiditis than in Graves' disease [7] . They occur in 17-40% of pediatric patients with type 1 diabetes [7, 8] appearing early before any clinical or biochemical signs of thyroid dysfunction. However, studies have shown that 50% of the subjects with positive antibodies may progress to develop autoimmune thyroid disease [4] .
Antimicrosomal antibodies, whose specific antigen has been identified as thyroid peroxidase (anti-TPO), an enzyme that catalyzes the iodination of tyrosine residues on thyroglobulin, are more often seen in type 1 diabetes with a prevalence of 25-50% of cases, and thyroglobulin antibodies (anti-TG) are present in 20-30% of cases [1] . Only few longitudinal studies have assessed the risk of thyroid autoimmunity (Th-AA) and diabetes [4, 5] and the optimal method or frequency of screening for Th-AA in patients with type 1 diabetes is still controversial [2, 3, 5] .
Kuwait has a high and increasing incidence of type 1 diabetes compared to other Arab countries [9] [10] [11] [12] . The age-standardized incidence in children aged 0-14 years in Kuwait between 1992 and 1999 was reported as 20.9/100,000 [10] . Studies on the prevalence of Th-AA in Arab children with type 1 diabetes are scarce [6, 13, 14] , and longitudinal studies assessing the risk of Th-AA are lacking. Therefore, we undertook this study to (1) investigate the prevalence and natural history of Th-AA among Arab children and adolescents with type 1 diabetes in Kuwait and (2) determine the clinical significance of the detection of TAA as a marker for autoimmune thyroid disease in children with type 1 diabetes.
Subjects and Methods
This study was done in the Pediatric Diabetes Unit, established at the Amiri Hospital, Kuwait, in 1998. Between1992 and 1999, a total of 266 children and adolescents with type 1 diabetes were registered in the diabetes outpatient clinic using a computer-based program (MS access). The study population included 232 patients (114 males and 118 females) below the age of 22 years (range 1-21) [15] in whom thyroid antibodies and thyroid-stimulating hormone (TSH) were measured. All patients were diagnosed with type 1 diabetes according to standard criteria, which included polyuria, polydipsia and unexplained weight loss as well as a casual plasma glucose concentration of ≥ 11.1 mmol/l (200 mg/dl) [3] . All subjects were screened annually for thyroid disease by measuring the TAA: anti-TPO, anti-TG, free thyroxine (FT 4 ) and sensitive thyroid-stimulating hormone (sTSH).The diagnosis of autoimmune thyroid disease was based on the clinical evaluation and detection of thyroid antibodies and abnormal thyroid function tests including sTSH and FT 4 .
Assays of anti-TPO and anti-TG were measured in the serum at the first clinic visit after the initiation of the study and repeated annually thereafter until a positive antibody test was found [2] . UniCAP TM (Pharmacia and Upjohn Company LLC, Kalamazoo, Mich., USA) anti-TG and anti-TPO are enzyme immunoassays for the qualitative and quantitative determination of anti-TG or anti-TPO in human serum or plasma, respectively. The cutoff values to enable clinical discrimination were: <60 IU/ml (normal), 60-100 IU/ml (equivocal) and >100 IU/ml (positive) for anti-TPO, and <280, 280-344 and >344 IU/ml for anti-TG. The negative control was <100 IU/ml. Thyroid function tests, sTSH and FT 4 were also measured in all the patients at their first clinic visit. These tests were repeated at a 6-month interval if TAA were detected and annually during the 4-9 years of follow-up if they were absent. The sTSH assay was determined by a continuous random access chemiluminescent immunoassay system (Abbott IMX). The test is a third-generation TSH assay having a functional sensitivity in the range of 0.01-0.02 μIU/ml, usually expressed in mIU/l in accordance with the international system of units. The strategy is to test third-generation TSH as a first-line test and then to measure FT 4 , if abnormal. The normal values for sTSH and FT 4 are 0.490-4.676 mIU/l and 9.14-23.81 pmol/l, respectively. Overt clinical hypothyroidism was defined as elevated TSH levels and triiodothyronine, thyroxine or FT 4 levels under the lower limit of normal. Subclinical hypothyroidism was defined as an elevated TSH level with normal triiodothyronine, thyroxine or FT 4 levels.
Statistical Analysis
The statistical analysis was carried out using descriptive statistics, including means and frequencies, and inferential statistics, that included using Student's t test and χ 2 test. Student's t test was used to test the significance of the differences between the mean values of two continuous variables. χ 2 analysis was performed to 
Results
The mean age of the study population was 10.9 ± 3.6 years (range 1-21), and the median diabetes duration was 3.9 years (range 0-16). Of the 232 pediatric subjects, 57 (24.6%) had positive TAA (23 males and 34 females), while 175 (75.4%) were antibody negative. The mean age of the subjects with type 1 diabetes who exhibited Th-AA was 11.75 ± 3.46 years (range 4-21) versus those without 10.63 ± 3.39 years (range 1-21), and the median duration of diabetes was 3 4.5 ± 3.73 and 3.79 ± 3.09 years in those with and without Th-AA, respectively. The clinical characteristics of the patients with positive and negative TAA are summarized in table 1 .
Of the 232 patients, at least 1 thyroid antibody was elevated in 57 (24.6%) patients, 20% (23/114) males and 29% (34/118) females. Of 57 patients with elevated thyroid antibody, 36 (63%) developed positive TAA within 5 years of the onset of diabetes and 21 (37%) after a 5-year duration of diabetes. The difference was statistically significant (p < 0.05) ( fig. 1 ). A subset of the study population (131 subjects) was prospectively followed for 4-9 years: 68 (51.9%) and 63 (48.1%) patients for 4 and 9 years: respectively, during which time 17.5% of them became TAA positive. Females were significantly more likely to develop Th-AA (58.7%, 47/80) than males (41%, 33/80, p < 0.0001). The TAA appeared more often after the onset of puberty in both sexes 77.5% (62/80) versus their appearance before puberty (22.5%, 18/80, p < 0.0001) ( fig. 2 ) .
The cumulative prevalence rate for positive Th-AA from both cross-sectional and longitudinal studies was 34.5% (80/232). Anti-TPO was present in 34 (14.7%) patients, anti-TG in 23 (9.9%) and both antibodies in 23 (9.9%) patients, with a statistically significant p value of 
Discussion
In this study, the prevalence of TAA observed in children with type 1 diabetes was high (34.5%) compared to other studies [7, 16, 17] . However, it is similar to the prevalence found in Iranian children (39.6%) [17] . Our results are considerably higher than those found in either Libyan [6] , Jordanian [9] , Saudi Arabian [13] and Sudanese children [14] .
It is well known that genetic predisposition contributes to the risk of developing type 1 diabetes, and the HLA class II locus contributes to the shared risk for both type 1 diabetes and autoimmune thyroid disease. The major haplotype contributing to this association is DR3DQB1 * 0201 [6] , which was significantly increased in Kuwaiti Arab children with type 1 diabetes [18] and may explain the high prevalence of Th-AA in the present study.
The frequency of thyroid antibodies in healthy Kuwaiti individuals in the general population was previously reported as 3.1%, being slightly higher in females [19] and increasing with other autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome. In contrast, a high frequency of thyroid dysfunction (55%) and of Th-AA (52%) was found in Kuwaiti adults with Down syndrome [20] . No studies examined the prevalence of Th-AA in healthy children in the general population in Kuwait.
The overall prevalence of Th-AA appeared to increase over time as reported by different authors [1, 6] . However, in this study, 63% of autoantibody-positive children developed Th-AA within 5 years of the onset of diabetes, a finding that emphasizes the importance of screening for thyroid antibodies early after the diagnosis of type 1 diabetes.
Our data showed a significant increase in positive autoantibodies in females, similar to other studies in the literature [8, 12, 17, 21, 22] where female sex was reported as an important risk factor for Th-AA. Furthermore, TAA appeared significantly more often after the onset of puberty in both sexes, 77.5 versus 22.5% before puberty. It is well accepted that in children at genetic risk of type 1 diabetes, seroconversion to anti-TPO peaks around the time of puberty, at which time the thyroid gland undergoes remodeling [6] .
Biochemical thyroid dysfunction may be present at the diagnosis of type 1 diabetes [4, 23] or may be detected after several decades of diabetes [4, 21, 23] . A strong association exists between Th-AA and the risk of thyroid dysfunction in people with type 1 diabetes with a risk ratio of 49 in children (95% CI 16-120) [24] . Furthermore, a prolonged period of autoimmunity makes the clinical diagnosis of thyroid autoimmune disease difficult, as it often occurs in a subclinical state. Measurements of thyroid function tests in clinically suspected cases or in those who have positive TAA would confirm the disease [17] .
Previous studies have shown a clear association of type 1 diabetes and autoimmune thyroiditis, often requiring treatment with L -thyroxine. The prevalence of autoimmune thyroiditis in our study as shown by abnormal thyroid function tests was 12.9% and compares well to other studies [8, 14, 25, 26] . The presence of subclinical hypothyroidism, which varies between 3 and 11% worldwide [6] , was found to be the most common dysfunction in our study (7.3%), followed by overt hypothyroidism (4.3%) and hyperthyroidism (1.2%). The latter finding is low compared to the prevalence reported in other studies (3-6%) [24 ] .
Despite the striking evidence that Th-AA with subclinical hypothyroidism [23, [26] [27] [28] [29] is a frequent finding in children and adolescents with type 1 diabetes, there is still controversy concerning the necessity of therapeutic intervention in these patients [30] . Mild thyroid failure has been extensively evaluated as a cardiovascular risk factor in adults, and neurobehavioral changes, myocardial dysfunction and dyslipidemia have frequently been described in this population [26] . Children with diabetes and subclinical hypothyroidism had reduced growth rates, particularly in those with TSH values of >10 IU/l, and therapy, when started early, reduced the risk of hyperlipidemia and atherosclerotic heart disease [30] . Although our decision was only to treat patients with TSH levels of >10 IU/l, this strategy would entail a close follow-up, as previous studies have shown that progression to clinical hypothyroidism occurs in 3-18% of patients per year [26, 28, 29, 31] . It has been recommended to start treatment with L -thyroxine if TSH increases ≥ 4.5 mIU/l on two subsequent measurements and/or if a thyroid gland enlargement with diffuse parenchymal hypoechogenicity on ultra-sound examination was present [4] . However, although thyroid imaging may be helpful, it is not a strict criterion for diagnosis.
Recently, the majority of studies have recommended annual screening for thyroid dysfunction and/or autoimmunity from diagnosis, while others recommend screening after the onset of puberty. However, the optimal methods and frequency of screening are yet to be established [24] .
Conclusion
The cumulative incidence of Th-AA from this mixed cross-sectional and longitudinal study was high, and subclinical hypothyroidism was the most common disorder diagnosed. The appearance of Th-AA early after diagnosis strongly supports the recommendation of screening all patients at the onset of diabetes, as early detection has the potential to prevent significant morbidity related to unrecognized disease.
